A multi-institutional team of neuroscientists has developed a nasal therapy that cleared the brains of Alzheimer’s mouse models of toxic tau proteins. In their study, published in the journal Science Translational Medicine, the group found a certain conformation-specific antibody that would bind to tau proteins, placed it inside of a shell that allowed it to travel through the blood brain barrier, and then tested it with mouse models.